AI Article Synopsis
Article Abstract
The new direct oral anticoagulants currently available are dabigatran, rivaroxaban and apixaban. These three drugs have been labeled in France for the prevention of venous thromboembolism after elective orthopaedic surgery including total hip or knee arthroplastly. Rivaroxaban is also labeled for the secondary prevention of thrombosis recurrence following an initial acute event. Pharmacologic properties of these drugs are reminded as well as the results of the main studies having conducted to their approval.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
direct oral
8
oral anticoagulants
8
[new direct
4
anticoagulants venous
4
venous thromboprophylaxis]
4
thromboprophylaxis] direct
4
anticoagulants currently
4
currently dabigatran
4
dabigatran rivaroxaban
4
rivaroxaban apixaban
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!